MAY, 2001

 

 STANDARD AND MAXIMUM ALLOWABLE CONCENTRATIONS FOR ADULT INTRAVENOUS MEDICATION DRIPS

 

All medications are intended for use in ICU or I-Care areas

(Shaded areas indicate exceptions for general floor administration)

 

 

MEdication

Standard admixture

Maximum concentration  (via central line) or special infusion instructionS

 

Abciximab

(Reoprỏ)

IV bolus: may be given undiluted

                (2 mg/mL vial)

 

Infusion: 10 mg/250 mL in D5W

                (40 mcg/mL)  

  

Must be filtered with a 0.2m filter before administering the bolus and the infusion.

12 hour expiration time, D5W or NS

Patients may also receive heparin

Alprostadil

1 mcg/mL in NS

(250 mcg/250 mL, 500 mcg/500 mL)

Various volumes may be used for final concentrations 1-20 mcg/mL

D5W or NS

24 hour stability

 

Alteplase

(TPA)

Arterial occlusion:

0.1 mg/mL in NS

 

Catheter clearance: 2 mg or 2.5 mg syringes available from pharmacy.  May be used in all patient care areas.

 

Various volumes used based on rate and anticipated infusion time

24 hour stability

 

(usual dose = 0.25-1 mg/hr x 6-24 hrs)

Amiodarone

(Cordaronẻ)

Load: 150 mg/100 mL D5W bag    

           (1.5 mg/mL)

 

Infusion: 900 mg/500 mL D5W glass        

               (1.8 mg/mL)

 

Cardiac arrest: 300 mg or 5 mg/kg

            bolus, flush with 10mL D5W

            (50 mg/mL amp)

 

1-6 mg/mL (900 mg/150 mL)

 

PVC bags only suitable for loading doses

 

Glass containers used for solutions given

over more than 2 hours

 

Concentrations over 2 mg/mL for longer  than 1 hour must infuse via central line


 

Argatroban

 

For HIT (heparin-induced thrombocytopenia)

1 mg/mL in NS

(125 mg/125 mL, 250 mg/250 mL)

Must be properly protected from light

 

1 mg/mL

NS or D5W

24 hour stability

Monitor aPTT and adjust dose as needed

Bumetanide

(Bumex̉)

 

0.25 mg/mL undiluted drug

(24 mg/96 mL)

 

Must be properly protected from light

 

May be further diluted per request

D5W or NS

Cisatracurium

(Nimbex̉)

IV bolus: may be given undiluted

                (10 mg/mL vial)

 

Infusion: 200 mg/100 mL NS

                (2 mg/mL)

 

2 mg/mL

NS or D5W

 

Train-of-Four monitoring

Diltiazem (Cardizem̉)

IV bolus: may be given undiluted

                (5 mg/mL vial)

 

Infusion: 100 mg/100 mL D5W 

                (1 mg/mL)

 

1 mg/mL 

D5W or NS

Dobutamine

1000 mg/250 mL D5W

(4000 mcg/mL)

 

Premade: 250/500/1000 mg in 250 mL D5W

 

5000 mcg/mL  (1250 mg/250 mL)

D5W or NS

Some institutions report up to

8000 mcg/mL (2000 mg/250 mL)

 

Dopamine

400 mg/250 mL D5W

(1600 mcg/mL)

 

Premade: 400/800 mg in 250 mL D5W

 

3200 mcg/mL  (800 mg/250 mL)

D5W or NS

Some institutions report up to

6400 mcg/mL (1600 mg/250 mL)

 

Epinephrine

4 mg/250 mL D5W

(16 mcg/mL)

 

2-120 mcg/mL in D5W or NS

(30 mg/250 mL for ACLS)

Eptifibatide

(Integrilin̉)

IV bolus: may be given undiluted

                (2 mg/mL vial)

 

Infusion: 75 mg/100 mL pre-made

               (0.75mg/mL)

 

Patients may also receive heparin

 

Esmolol

(Brevibloc̉)

IV bolus: may be given undiluted

**only use 10 mg/mL amp for this**

 

Infusion: 10 mg/mL in D5W

(2500 mg/250 mL, 5000 mg/500 mL)

 

10 mg/mL in D5W or NS

Some institutions report up to

20 mg/mL (5000 mg/250 mL)


 

Fenoldopam

(Corlopam̉)
Must meet guideline criteria for use

 

40 mcg/mL in NS

(10 mg/250 mL, 20 mg/500 mL)

200 mcg/mL in NS or D5W 

(20 mg/100 mL)

Manufacturer states up to 273 mcg/mL

Fentanyl

 

Infusion: 10 mcg/mL in NS 

               (1000 mcg/100 mL)

 

PCA: 50 mcg/mL undiluted drug

          (2500 mcg/50 mL)

 

Epidural: 2.5, 5 or 10 mcg/mL with bupivicaine 0.125% in 250 mL NS

 

50 mcg/mL undiluted drug

May be further diluted per request

Furosemide

(Lasix̉)

 

10 mg/mL undiluted drug

(1000 mg/100 mL)

Must be properly protected from light

May be further diluted per request:

1-10 mg/mL

D5W or NS

Heparin

40 units/mL in D5W

(20,000 units/500 mL)

 

Various concentrations given for IV use

Maximum infusion concentration

200 units/mL

 

Hydromorphone

(Dilaudid̉)

PCA: 40 mg/200 mL NS

          (0.2 mg/mL)

10 mg/mL undiluted

May be diluted per request to yield various concentrations for PCA or continuous infusion, D5W or NS

 

Insulin, regular

1 unit/mL in NS

(100 units/100 mL)

 

0.1-1 unit/mL in NS or ½NS

Isoproterenol

(Isuprel̉)

1 mg/250 mL D5W

 (4 mcg/mL)

20 mcg/mL in D5W or NS

Some institutions report up to

40 mcg/mL (10 mg/250 mL)

 

Lepirudin (Refludan̉)

 

For HIT (heparin-induced thrombocytopenia)

IV bolus: 5 mg/mL in NS

                (prepared in syringe)

 

Infusion: 100 mg/500 mL NS

                (0.2 mg/mL)

 

100 mg/250 mL NS or D5W

(0.4 mg/mL)

24 hr stability

Monitor aPTT and adjust dose if needed

Lidocaine

(Xylocainẻ)

4000 mg/500 mL D5W

(8 mg/mL)

8 mg/mL in D5W

Some institutions report up to

16 mg/mL (4000 mg/250 mL)

 

Lorazepam

(Ativan̉)

1 mg/mL in D5W glass bottle only

(40 mg/40 mL, 80 mg/80 mL)

 

Must be properly protected from light.

0.1, 0.2 and 1 mg/mL

D5W or NS glass bottle

Short stability, depends on final concentration

Midazolam

(Versed̉)

50 mg/50 mL NS 

(1 mg/mL)

 

0.5-2 mg/mL in D5W or NS

May be diluted per request

Milrinone

(Primacor̉)

 

Load:  May be given undiluted

            (1 mg/mL vial)

 

IV infusion: 20 mg/100 mL D5W

                     (0.2 mg/mL) pre-made

 

100 mg/250 mL in D5W or NS

(0.4 mg/mL)

Morphine

Infusion: 100 mg/100 mL D5W 

                (1 mg/mL)

          

PCA: 300 mg/30 mL SW

          (10 mg/mL)

 

May be diluted per request to yield various concentrations

Nicardipine

(Cardenẻ)

0.1 mg/mL in NS

(25 mg/250 mL, 50 mg/500 mL)

0.2 mg/mL in NS or D5W

(50 mg/250 mL), must be in central line

 

Nitroglycerin

 

50 mg/250 mL D5W glass bottle

(200 mcg/mL)

25-400 mcg/mL

(100 mg/250 mL)

D5W or NS glass bottle

Some institutions report up to

800 mcg/mL (200 mg/250 mL)

 

Nitroprusside

(Nitropress̉)

50 mg/250 mL in D5W

 (200 mcg/mL)

 

Must be properly protected from light

 

50-400 mcg/mL in D5W or NS

(100 mg/250 mL)

Some institutions report up to  

800 mcg/mL (200 mg/250 mL)

Norepinephrine

(Levophed̉)

4 mg/250 mL D5W

(16 mcg/mL)

 

(NS alone not recommended due to loss of potency from oxidation)

 

4-64 mcg/mL in D5W or D5W ½ NS

(16 mg/250 mL)

Some institutions report 80-128 mcg/mL

(20-32 mg/250 mL)

 

Octreotide

(Sandostatin̉)

 

IV bolus: may be given undiluted

 

Infusion: 500 mcg/100 mL NS bag

               (5 mcg/mL)

 

10 mcg/mL in NS or D5W bag or glass

May be diluted per request

Pancuronium

(Pavulon̉)

 

IV bolus: may be given undiluted

                (1 mg/mL)

 

Infusion: 100 mg/100 mL undiluted

               (1 mg/mL)

 

1 mg/mL

Train-of-Four monitoring

Phenylephrine

(Neosynephrinẻ)

10 mg/250 mL NS

(40 mcg/mL)

20-160 mcg/mL in NS or D5W

(40 mg/250 mL)

Some institutions report up to

400 mcg/mL  (100 mg/250 mL)

 

Procainamide

(Pronestyl̉)

Load: 500-1000 mg diluted to a final concentration of 20-30 mg/mL D5W

 

Infusion: 1000 mg/250 mL D5W

               (4 mg/mL)

 

16 mg/mL in D5W or NS for infusion

(4000 mg/250 mL)

Propofol

(Diprivan̉)

1000 mg/100 mL glass bottle

(10 mg/mL)

 

1% Lipid emulsion, 1.1 Kcal/mL

10 mg/mL undiluted drug

 

May be further diluted using only D5W to a concentration no less than 2 mg/mL

Tirofiban (Aggrastat̉)

12.5 mg/250 mL bag

(50 mcg/mL)

 

50 mcg/mL in NS or D5W

Patients may also receive heparin

Vecuronium

(Norcuron̉)

 

100 mg/100 mL NS

(1 mg/mL)

0.1-1 mg/mL in NS or D5W

Train-of-Four monitoring

  

Information compiled using clinical practice guidelines from the University of Kansas, University of Iowa and University of Virginia Surgery Service Center.

 

Sodorff, MM, Galt, KA, Galt, M, Foral, PA.  Recommended Maximum Concentrations of Common Acute   Care Parenteral Admixtures. Hospital Pharmacy. Volume 34, Number 8, pp 937-942.

 

Gahart, BL, Nazareno, AR.  2001 Intravenous Medications, 17th Edition.

 

Table prepared by Kristen A. Brown Pharm.D.